The firm's new strategy revolves around adding to its test menu in an impactful way and expanding its installed base of instruments.

Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect ...

Recognizing early liver disease signs is crucial as many conditions develop silently. Persistent fatigue, jaundice, abdominal swelling, confusion, fre ...

Jefferies London Healthcare Conference 2025 November 20, 2025 3:00 AM ESTCompany ParticipantsVipin Garg - President, CEO ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

Molecular profiles will give detailed snapshot of person’s physiology and predict diseases from diabetes to cancer and dementia ...

Managing diabetes with injections is challenging. Joining insulin to a skin-penetrating polymer was as effective as shots at regulating blood sugar.

Even newer “minimally invasive” ideas, like stent-mounted electrodes deployed through blood vessels, still require a catheter ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Abstract: This study introduces a liver fibrosis staging method based on the fusion of multi-modal imaging features. By leveraging ultrasound gray-scale images and ultrasound shear wave elastography ...

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

Australia fast bowler Josh Hazlewood will miss at least the first Ashes test against England beginning in Perth next Friday due to a hamstring injury. Initial scans cleared him of major damage, ...